BFA
BIO icon

BlackRock Fund Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

BlackRock Fund Advisors’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$159M Buy
873,392
+43,748
+5% +$7.46M 0.03% 831
2016
Q3 		$136M Buy
829,644
+21,624
+3% +$3.28M 0.03% 834
2016
Q2 		$116M Buy
808,020
+62,178
+8% +$8.87M 0.03% 860
2016
Q1 		$102M Buy
745,842
+7,412
+1% +$973K 0.02% 941
2015
Q4 		$102M Buy
738,430
+40,229
+6% +$5.58M 0.02% 934
2015
Q3 		$93.8M Sell
698,201
-11,367
-2% -$1.64M 0.02% 956
2015
Q2 		$107M Buy
709,568
+26,182
+4% +$3.75M 0.03% 942
2015
Q1 		$92.4M Buy
683,386
+30,692
+5% +$3.8M 0.02% 1067
2014
Q4 		$78.7M Buy
652,694
+7,510
+1% +$864K 0.02% 1138
2014
Q3 		$73.2M Buy
645,184
+24,059
+4% +$2.85M 0.02% 1088
2014
Q2 		$74.4M Buy
621,125
+50,199
+9% +$6.13M 0.02% 1119
2014
Q1 		$73.1M Sell
570,926
-12,149
-2% -$1.56M 0.02% 1103
2013
Q4 		$72.1M Buy
583,075
+15,253
+3% +$1.86M 0.02% 1112
2013
Q3 		$66.8M Buy
567,822
+21,157
+4% +$2.5M 0.02% 1085
2013
Q2 		$61.3M Buy
+546,665
New +$64.1M 0.02% 1050

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

BlackRock Fund Advisors's BIO Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Bio-Rad Laboratories Class A (BIO) stake by 5.3% in Q4 2016, buying an estimated $7.46M and bringing the position to 873,392 shares worth $159M. The position accounts for 0.03% of the portfolio, ranked #831.

BlackRock Fund Advisors first reported a position in BIO in Q2 2013 and has held it in 15 quarters since. 260 funds tracked by Wall St. Rank hold BIO as of Q4 2016.

  • BlackRock Fund Advisors held 873,392 shares of Bio-Rad Laboratories Class A worth $159M as of Q4 2016.
  • BlackRock Fund Advisors bought 43,748 Bio-Rad Laboratories Class A shares in Q4 2016, an estimated $7.46M.
  • Bio-Rad Laboratories Class A made up 0.03% of BlackRock Fund Advisors's portfolio in Q4 2016, its #831 holding.
  • BlackRock Fund Advisors first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and has held it in 15 quarters since.
  • 260 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.